| 000 | 01815 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517011601.0 | ||
| 264 | 0 | _c20160503 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1938-0682 | ||
| 024 | 7 |
_a10.1016/j.clgc.2014.11.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAutio, Karen A | |
| 245 | 0 | 0 |
_aSevere Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians. _h[electronic resource] |
| 260 |
_bClinical genitourinary cancer _cAug 2015 |
||
| 300 |
_ae305-e309 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCalcium _xadministration & dosage |
| 650 | 0 | 4 |
_aDenosumab _xadministration & dosage |
| 650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypocalcemia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProstatic Neoplasms, Castration-Resistant _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aFarooki, Azeez | |
| 700 | 1 | _aGlezerman, Ilya G | |
| 700 | 1 | _aChan, Amelia | |
| 700 | 1 | _aSchneider, Coursen W | |
| 700 | 1 | _aBarr, Hallie C | |
| 700 | 1 | _aSeyboth, Brian M | |
| 700 | 1 | _aKampel, Lewis J | |
| 700 | 1 | _aDanila, Daniel C | |
| 700 | 1 | _aRathkopf, Dana E | |
| 700 | 1 | _aSlovin, Susan F | |
| 700 | 1 | _aScher, Howard I | |
| 700 | 1 | _aMorris, Michael J | |
| 773 | 0 |
_tClinical genitourinary cancer _gvol. 13 _gno. 4 _gp. e305-e309 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clgc.2014.11.008 _zAvailable from publisher's website |
| 999 |
_c24506197 _d24506197 |
||